ID

18292

Description

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT00333138

Lien

https://clinicaltrials.gov/show/NCT00333138

Mots-clés

Versions (1)
  1. 28/10/2016 28/10/2016 -
Téléchargé le

28 octobre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Multiple Sclerosis NCT00333138

Anglais

Eligibility Multiple Sclerosis NCT00333138

1 Formulaires  
Criteria
Description

Criteria

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of relapsing multiple sclerosis (ms)
Description

Multiple Sclerosis, Acute Relapsing

Type de données

boolean

Alias
UMLS CUI [1]
C0393664
patients with at least two documented relapses in the previous 2 years or one documented relapse in the last year
Description

Relapse Quantity Period

Type de données

boolean

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1948053
patients with an expanded disability status scale (edss) score of 0-6
Description

EDSS

Type de données

boolean

Alias
UMLS CUI [1]
C0451246
extension study
Description

Extension Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231448
UMLS CUI [1,2]
C0008976
a positive gd-enhanced mri scan at screening (in case the first mri scan obtained at screening was negative, a second scan could have been obtained 1 month later)
Description

Nuclear magnetic resonance imaging gadolinium-enhanced Positive | Magnetic Resonance Imaging

Type de données

boolean

Alias
UMLS CUI [1,1]
C0855566
UMLS CUI [1,2]
C1514241
UMLS CUI [2]
C0024485
neurologically stable with no evidence of relapse within 30 days prior to randomization,or during the screening and baseline periods.
Description

Neurologic Stable | Relapse Evidence

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205494
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0035020
UMLS CUI [2,2]
C3887511
female patients either post-menopausal, surgically incapable of bearing children, or practicing an acceptable method of birth control. females of childbearing potential with a negative pregnancy test at baseline prior to entry into the treatment period.
Description

Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Childbearing Potential Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0015787
UMLS CUI [4]
C0700589
UMLS CUI [5,1]
C3831118
UMLS CUI [5,2]
C0427780
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
core study
Description

Clinical Trial Main

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C1542147
patients with other chronic disease of the immune system, malignancies, pulmonary or heart disease, etc
Description

Chronic disease of immune system | Malignant Neoplasms | Lung diseases | Heart Diseases

Type de données

boolean

Alias
UMLS CUI [1]
C1290894
UMLS CUI [2]
C0006826
UMLS CUI [3]
C0024115
UMLS CUI [4]
C0018799
pregnant or nursing women
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
extension study
Description

Extension Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231448
UMLS CUI [1,2]
C0008976
patients who had permanently discontinued study drug prior to the month 6 visit of the core study
Description

Investigational New Drug Discontinued Permanent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0205355
patients with diabetes mellitus (to reduce the risk of me), and therefore ongoing patients with diabetes mellitus or who developed diabetes mellitus were discontinued from the study)
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
other protocol-defined inclusion/exclusion criteria may apply
Description

Clinical Trial Eligibility Criteria Study Protocol

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Retour au début de la page

Similar models

Eligibility Multiple Sclerosis NCT00333138

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Multiple Sclerosis, Acute Relapsing
Item
diagnosis of relapsing multiple sclerosis (ms)
boolean
C0393664 (UMLS CUI [1])
Relapse Quantity Period
Item
patients with at least two documented relapses in the previous 2 years or one documented relapse in the last year
boolean
C0035020 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1948053 (UMLS CUI [1,3])
EDSS
Item
patients with an expanded disability status scale (edss) score of 0-6
boolean
C0451246 (UMLS CUI [1])
Extension Clinical Trial
Item
extension study
boolean
C0231448 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Nuclear magnetic resonance imaging gadolinium-enhanced Positive | Magnetic Resonance Imaging
Item
a positive gd-enhanced mri scan at screening (in case the first mri scan obtained at screening was negative, a second scan could have been obtained 1 month later)
boolean
C0855566 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0024485 (UMLS CUI [2])
Neurologic Stable | Relapse Evidence
Item
neurologically stable with no evidence of relapse within 30 days prior to randomization,or during the screening and baseline periods.
boolean
C0205494 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0035020 (UMLS CUI [2,1])
C3887511 (UMLS CUI [2,2])
Gender | Postmenopausal state | Female Sterilization | Contraceptive methods | Childbearing Potential Pregnancy test negative
Item
female patients either post-menopausal, surgically incapable of bearing children, or practicing an acceptable method of birth control. females of childbearing potential with a negative pregnancy test at baseline prior to entry into the treatment period.
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0700589 (UMLS CUI [4])
C3831118 (UMLS CUI [5,1])
C0427780 (UMLS CUI [5,2])
Item Group
C0680251 (UMLS CUI)
Clinical Trial Main
Item
core study
boolean
C0008976 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Chronic disease of immune system | Malignant Neoplasms | Lung diseases | Heart Diseases
Item
patients with other chronic disease of the immune system, malignancies, pulmonary or heart disease, etc
boolean
C1290894 (UMLS CUI [1])
C0006826 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Extension Clinical Trial
Item
extension study
boolean
C0231448 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Investigational New Drug Discontinued Permanent
Item
patients who had permanently discontinued study drug prior to the month 6 visit of the core study
boolean
C0013230 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0205355 (UMLS CUI [1,3])
Diabetes Mellitus
Item
patients with diabetes mellitus (to reduce the risk of me), and therefore ongoing patients with diabetes mellitus or who developed diabetes mellitus were discontinued from the study)
boolean
C0011849 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial